A Novel Microchannel-based Device to Capture and Analyze Circulating Tumor Cells (CTCs) of Breast Cancer

Overview

Journal Int J Oncol

Specialty Oncology

Date 2014 Mar 29

PMID 24676558

Citations 40

Authors

Reza Riahi

Priyadarshini Gogoi

Saedeh Sepehri

Yi Zhou

Kalyan Handique

Jim Godsey

Yixin Wang

Affiliations

Soon will be listed here.

Abstract

Circulating tumor cells (CTCs) have been shown in many studies as a possible biomarker for metastasis and may be instrumental for the spread of the disease. Despite advances in CTC capturing technologies, the low frequency of CTCs in cancer patients and the heterogeneity of the CTCs have limited the wide application of the technology in clinic. In this study, we investigated a novel microfluidic technology that uses a size- and deformability-based capture system to characterize CTCs. This unique platform not only allows flexibility in the selection of antibody markers but also segregates the CTCs in their own chambers, thus, enabling morphological, immunological and genetic characterization of each CTC at the single cell level. In this study, different breast cancer cell lines including MCF7, MDA-MB-231 and SKBR3, as well as a panel of breast cancer biomarkers were used to test the device. The technology can capture a wide range of cells with high reproducibility. The capturing efficiency of the cells is greater than 80%. In addition, the background of leukocytes is minimized because individual cells are segregated in their own chambers. The device captured both epithelial cancer cells such as MCF7 and SKBR3 and mesenchymal cells such as MDA-MB-231. Immunostaining of the captured cells on the microchannel device suggests that a panel of breast cancer biomarkers can be used to further characterize differential expression of the captured cells.

Citing Articles

Potential role of circulating tumor cells and cell-free DNA as biomarkers in oral squamous cell carcinoma: A prospective single-center study.

Eboshida N, Hamada A, Higaki M, Obayashi F, Ito N, Yamasaki S PLoS One. 2024; 19(12):e0309178.

PMID: 39729421 PMC: 11676868. DOI: 10.1371/journal.pone.0309178.

Decoding physical principles of cell migration under controlled environment using microfluidics.

Suh Y, Li A, Pandey M, Nordmann C, Huang Y, Wu M Biophys Rev (Melville). 2024; 5(3):031302.

PMID: 39091432 PMC: 11290890. DOI: 10.1063/5.0199161.

Numerical Simulations of Combined Dielectrophoresis and Alternating Current Electrothermal Flow for High-Efficient Separation of (Bio)Microparticles.

Jiang H, Li Y, Du F, Nie Z, Wei G, Wang Y Micromachines (Basel). 2024; 15(3).

PMID: 38542592 PMC: 10971919. DOI: 10.3390/mi15030345.

Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer.

Dhaka S, Tripathi R, Chandra Doval D, Mehta A, Maheshwari U, Koyyala V South Asian J Cancer. 2023; 12(1):62-67.

PMID: 36851934 PMC: 9966169. DOI: 10.1055/s-0042-1753477.

Recent Advances in Methods for Circulating Tumor Cell Detection.

Vidlarova M, Rehulkova A, Stejskal P, Prokopova A, Slavik H, Hajduch M Int J Mol Sci. 2023; 24(4).

PMID: 36835311 PMC: 9959336. DOI: 10.3390/ijms24043902.

References

Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M . Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res. 2008; 14(9):2593-600. DOI: 10.1158/1078-0432.CCR-07-4758. View

Zhang Z, Nagrath S . Microfluidics and cancer: are we there yet?. Biomed Microdevices. 2013; 15(4):595-609. PMC: 4017600. DOI: 10.1007/s10544-012-9734-8. View

Tang P, Skinner K, Hicks D . Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?. Diagn Mol Pathol. 2009; 18(3):125-32. DOI: 10.1097/PDM.0b013e31818d107b. View

Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B . Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007; 13(3):920-8. DOI: 10.1158/1078-0432.CCR-06-1695. View

Weigelt B, Peterse J, J van t Veer L . Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005; 5(8):591-602. DOI: 10.1038/nrc1670. View

Cristofanilli M, Hayes D, Budd G, Ellis M, Stopeck A, Reuben J . Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005; 23(7):1420-30. DOI: 10.1200/JCO.2005.08.140. View

Allan A, Keeney M . Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol. 2010; 2010:426218. PMC: 2798617. DOI: 10.1155/2010/426218. View

Ring A, Zabaglo L, Ormerod M, Smith I, Dowsett M . Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer. 2005; 92(5):906-12. PMC: 2361897. DOI: 10.1038/sj.bjc.6602418. View

10.

Punnoose E, Atwal S, Spoerke J, Savage H, Pandita A, Yeh R . Molecular biomarker analyses using circulating tumor cells. PLoS One. 2010; 5(9):e12517. PMC: 2935889. DOI: 10.1371/journal.pone.0012517. View

11.

Wicha M, Hayes D . Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. J Clin Oncol. 2011; 29(12):1508-11. DOI: 10.1200/JCO.2010.34.0026. View

12.

Kirby B, Jodari M, Loftus M, Gakhar G, Pratt E, Chanel-Vos C . Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PLoS One. 2012; 7(4):e35976. PMC: 3338784. DOI: 10.1371/journal.pone.0035976. View

13.

Smirnov D, Zweitzig D, Foulk B, Miller M, Doyle G, Pienta K . Global gene expression profiling of circulating tumor cells. Cancer Res. 2005; 65(12):4993-7. DOI: 10.1158/0008-5472.CAN-04-4330. View

14.

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

15.

Dong Y, Skelley A, Merdek K, Sprott K, Jiang C, Pierceall W . Microfluidics and circulating tumor cells. J Mol Diagn. 2012; 15(2):149-57. DOI: 10.1016/j.jmoldx.2012.09.004. View

16.

Maheswaran S, Haber D . Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev. 2010; 20(1):96-9. PMC: 2846729. DOI: 10.1016/j.gde.2009.12.002. View

17.

Saliba A, Saias L, Psychari E, Minc N, Simon D, Bidard F . Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc Natl Acad Sci U S A. 2010; 107(33):14524-9. PMC: 2930475. DOI: 10.1073/pnas.1001515107. View

18.

Li P, Stratton Z, Dao M, Ritz J, Huang T . Probing circulating tumor cells in microfluidics. Lab Chip. 2013; 13(4):602-9. PMC: 3990734. DOI: 10.1039/c2lc90148j. View

19.

Sieuwerts A, Mostert B, Vries J, Peeters D, de Jongh F, Stouthard J . mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res. 2011; 17(11):3600-18. DOI: 10.1158/1078-0432.CCR-11-0255. View

20.

Reinholz M, Nibbe A, Jonart L, Kitzmann K, Suman V, Ingle J . Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res. 2005; 11(10):3722-32. DOI: 10.1158/1078-0432.CCR-04-1483. View